S2212
OPEN TO ACCRUAL
Anthracycline-Free Chemo Immunotherapy Adapted to Path Response in Early Triple Neg BC (Scarlet)
UW16106
OPEN TO ACCRUAL
Neoadjuvant Weekly Paclitaxel and Biomarkers of Therapy Response
UW25069
OPEN TO ACCRUAL
Study to Evaluate Efficacy & Safety of sac-TMT by Carboplatin/Paclitaxel vs Chemo, in Combo w/Pembro